Duncan Bucknell

Strategic Intellectual Property

Menu
  • Our Services
  • Insights & News
  • How we help you succeed
  • About us

Duncan Bucknell

Strategic Intellectual Property

Duncan

Posts by Duncan:
  • The global Lipitor patent battle
  • Value for money in global patent litigation
  • Pharmaceutical IP Strategy in the US – Merck’s latest tactic for Zocor
  • Fosamax once weekly patent invalid on appeal in Australian Full Federal Court
  • Analysing IP – put simply
  • Canadian Supreme Court allows third party registration of famous mark (‘Barbie’) for dissimilar goods (a restaurant chain)
  • Canadian Supreme Court holds ‘Cliquot’ for women’s clothing not likely to cause confusion with ‘Veuve Clicquot’ for luxury Champagne
  • Spanish Appellate Court applies Bolar while denying interim injunction in Finasteride decision
  • Zocor Generic Exclusivity dispute continues on appeal in the US
  • Experts and skilled addressee come to the fore in UK Patents Court Eloxatin decision
« 1 … 142 143 144 145 146 »
Duncan Bucknell
duncan@duncanbucknell.com
+61 427 003 423

Insights & News

  • Commercial IP, deals and contracts
  • Disputes and Litigation
  • IP Rights
    • Brands and Trade Marks
    • Copyright and Designs
    • Inventions & Patents
    • Trade Secrets
  • Strategic Advice
    • Coaching
    • Develop IP
    • Enforce and defend your IP
    • Increase IP Value
    • Inform and improve your IP Strategy
    • IP Management
    • Product Strategy
    • Pursue Excellence
    • Risk management

Duncan Bucknell

 

Loading Comments...
 

You must be logged in to post a comment.